CURRENT PIPELINE

				STAGE OF DEVELOPMENT
Program	Approach	Indication	Discovery	Lead Optimization	IND Enabling
PLA-GBM™ (Internal)	Platelet-mediated delivery of siRNA/miRNA	Glioblastoma			2023
PLA-ONCO™ (Out-Licensing)* or (For Partnering)*	Platelet-mediated delivery of siRNA	Solid Tumors			2024

Rotate Screen from Mobile Devices

(*) Plasfer is actively looking for partners to move this program forward